SLC11A1

Across TCGA pan-cancer cohorts, SLC11A1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SLC11A1 data layer compared with 24 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SLC11A1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLC11A1 expression acts as an unfavorable survival marker.

LUAD, GBM, and PDAC are the cancer types where SLC11A1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Quartile	All	0.508	0.926	<.001	50	view →
GBM	DFS	Median	All	0.587	0.919	<.001	19	view →
PDAC	DFS	Median	All	0.218	0.536	.026	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

SLC11A1–LUAD (DFS)

Open the LUAD breakdown →